Literature DB >> 19486232

A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma.

J P Ortonne1, I Arellano, M Berneburg, T Cestari, H Chan, P Grimes, D Hexsel, S Im, J Lim, H Lui, A Pandya, M Picardo, M Rendon, S Taylor, J P W Van Der Veen, W Westerhof.   

Abstract

BACKGROUND: It has been generally believed that the four main causes of melasma are pregnancy, hormonal contraception, family history and sun exposure; however, there are few published comprehensive studies that confirm these assertions. The Pigmentary Disorders Academy - an international group of experts in pigmentary disorders - designed and conducted a global survey of women to investigate the effect of these factors on onset and chronicity of melasma and the course of the disease in order to gain a better understanding of the causative factors associated with this disorder, with a particular focus on hormonal factors and UV exposure in females.
METHODS: A 40-item largely self-administered questionnaire was completed by 324 women being treated for melasma in nine clinics worldwide.
RESULTS: The mean age at onset of melasma was 34 years, and 48% of subjects questioned had a family history of melasma (97% in a first-degree relative). Subjects with family history of melasma tended to have darker skin (90% types III-VI) compared to those without (77% types III-VI). The most common time of onset was after pregnancy (42%), often years after the last pregnancy, with 29% appearing pre-pregnancy and 26% during pregnancy. Onset was related to darker skin type post-pregnancy (P = 0.002). Risk of onset during pregnancy was associated with having spent more time outdoors (an extra 10 h per week spent working outside increases the odds of onset of melasma during pregnancy by approximately 27%) and an increased maternal age at pregnancy (increased by approximately 8% for each year of age at first pregnancy; P = 0.02). The odds of melasma occurring for the first time during a pregnancy were also increased with multiple pregnancies (twice the odds if 2 vs. 1 pregnancies, three times higher if 3 or more vs. 1 pregnancy). Of the women, 25% who had used hormonal contraception claimed that melasma appeared for the first time after its use, the rate being higher for those without vs. with a family history.
CONCLUSIONS: The results suggest that, whilst accepted causes do affect onset of melasma, a combination of these factors often triggers this disorder. These factors may provide further insights into how physicians can manage individual melasma cases, support recommendation of preventative measures and even anticipate treatment results and recurrence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486232     DOI: 10.1111/j.1468-3083.2009.03295.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  34 in total

1.  What should be considered in treatment of melasma.

Authors:  Hee Young Kang; Jean-Paul Ortonne
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

Review 2.  [Melasma : An update on the clinical picture, treatment, and prevention].

Authors:  S Becker; C Schiekofer; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

3.  Efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin cream in chinese patients with melasma: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.

Authors:  Zijian Gong; Wei Lai; Guang Zhao; Xuemin Wang; Min Zheng; Li Li; Qingqi Yang; Yuping Dang; Lunfei Liu; Ying Zou
Journal:  Clin Drug Investig       Date:  2015-06       Impact factor: 2.859

4.  Sebocytes contribute to melasma onset.

Authors:  Enrica Flori; Arianna Mastrofrancesco; Sarah Mosca; Monica Ottaviani; Stefania Briganti; Giorgia Cardinali; Angela Filoni; Norma Cameli; Marco Zaccarini; Christos C Zouboulis; Mauro Picardo
Journal:  iScience       Date:  2022-02-04

Review 5.  Topical Treatments for Melasma and Their Mechanism of Action.

Authors:  Valeria González-Molina; Alicia Martí-Pineda; Noelani González
Journal:  J Clin Aesthet Dermatol       Date:  2022-05

Review 6.  Melasma in Men: A Review of Clinical, Etiological, and Management Issues.

Authors:  Rashmi Sarkar; Pallavi Ailawadi; Shilpa Garg
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

7.  Low-power Fractional Carbon Dioxide Laser Followed by Jessner's Peel versus Jessner's Peel Alone for the Treatment of Melasma.

Authors:  Eman Elmorsy; Nouran Aboukhadr; Maha Tayyeb; Alsayeda A A Taha
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

8.  Korean red ginseng powder in the treatment of melasma: an uncontrolled observational study.

Authors:  Margaret Song; Je-Ho Mun; Hyun-Chang Ko; Byung-Soo Kim; Moon-Bum Kim
Journal:  J Ginseng Res       Date:  2011-06       Impact factor: 6.060

9.  Low Prevalence of Pregnancy-Mask among Igbo Women in Enugu, Nigeria.

Authors:  Po Nkwo
Journal:  Ann Med Health Sci Res       Date:  2011-07

10.  The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.

Authors:  Hassan Adalatkhah; Homayoun Sadeghi-Bazargani
Journal:  Drug Des Devel Ther       Date:  2015-08-04       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.